Australia's Resonance Health soars on FDA approval for medical device

Resonance Health

29/12/2021 23:49

** Shares of Resonance Health Ltd  RHT.AX  soar as much as
54.6% to A$0.17, set for their sharpest daily gain since
December 2020 
    ** Medical imaging software developer says its medical
device for MRI scan of liver-iron and fat Liversmart received
clearance from the U.S Food and Drug Administration  urn:newsml:reuters.com:*:nASX2F6twQ
    ** Co says clearance allows the device to be commercially
marketed and sold in the United States, which has its largest
customer base  
    ** Stock hits highest since Dec. 21 
    ** Volume 12.1 times the 30-day average of 205,924
    ** As of Wednesday's close, stock had tumbled 54.17% this
year

 (Reporting by Navya Mittal)
 ((Navya.Mittal@thomsonreuters.com;))